OasisLMS

Release Date: March 3, 2024

Expiration Date: March 2, 2027

This recorded webinar provides a comprehensive overview of neuromodulation therapies for the treatment of chronic craniofacial pain. Expert faculty examine the underlying mechanisms and clinical indications for neuromodulation, discuss key considerations in patient selection, and review the range of available treatment options, from peripheral nerve stimulation to emerging neuromodulation technologies.

Through faculty presentations and panel discussion, learners will gain practical insights into evaluating candidates for craniofacial pain neuromodulation and selecting appropriate therapeutic approaches based on patient characteristics and clinical presentation. The activity also explores evolving innovations in the field, equipping clinicians with a deeper understanding of current and future neuromodulation strategies for managing complex craniofacial pain conditions.

To access the NANS eLearning Center and register for this content, log in using your NANS account username and password.

• Have a NANS account? Click Login.
• Need an account? Click Create Account and complete the form.
• Questions about your NANS account? Email membership@nans.org or call (773) 648-7845 (Mon–Fri, 8:30 AM–5:00 PM CT).

Following participation in this activity, learners will be able to:

• Describe the indications and underlying mechanisms of neuromodulation for craniofacial pain.
• Systematically assess and select appropriate candidates for craniofacial pain neuromodulation.
• Explore the different neuromodulation options available for craniofacial pain management from peripheral nerve stimulation to emerging techonogies.

Welcome
Yashar Eshraghi, MD

Indications and Mechanism for Neuromodulation for Craniofacial Pain
Konstantin Slavin, MD

Patient Selection in Craniofacial Pain Neuromodulation
Sameer Narouze, MD, PhD

Neuromodulation Treatment Types and Variations for Craniofacial Pain
Miles Day, MD

Panel Discussion and Q&A
All faculty 

Conclusion
Yashar Eshraghi, MD

None of the planners, staff, reviewers or faculty have any relevant financial relationships to disclose with ACCME ineligible companies except those listed below. All relevant relationships have been mitigated. 

Konstantin V. Slavin, Faculty: Abbott/St. Jude Medical; Boston Scientific; Medtronic; Contracted Research; Neuros (relationship ended); Contracted Research
Abbott/St. Jude Medical; Biotronik; Saluda Medical; Nuvectra; Consulting Fee
Thermaquil; Neuramodix; Stock Options

Mark N. Malinowski Webinar Subcommittee Chair; Reviewer: Abbott/St. Jude Medical; Biotronik; Consulting Fee; Nalu Medical; SI Bone, Inc (relationships ended); Consulting Fee